Jeffrey Lawrence Schwartz, Director at SpringWorks Therapeutics, Inc. (SWTX), sold 1,750,000 shares at $28.50 ($49.9M) on 2023-03-16, disclosed to the SEC on 2023-03-20.
Open-market sale of $49.9M SWTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.